SK-MES-1细胞

SK-MES-1/SK-MES-1细胞系/SK-MES-1细胞株/SK-MES-1人肺鳞癌细胞

Cell line name SK-MES-1

Synonyms SK MES 1; SKMES-1; SK-Mes-1; SK-MES1; SKMES1; SK-MES; SKMES

Accession CVCL_0630

Secondary accession CVCL_8913

Resource Identification Initiative To cite this cell line use: SK-MES-1 (RRID:CVCL_0630)

Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

Part of: COSMIC cell lines project.

Part of: MD Anderson Cell Lines Project.

From: Memorial Sloan Kettering Cancer Center; New York; USA.

Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2009-091.

Population: Caucasian.

Doubling time: ~50 hours (DSMZ=ACC-353).

Microsatellite instability: Stable (MSS) (Sanger).

Omics: Array-based CGH.

Omics: CRISPR phenotypic screen.

Omics: Deep exome analysis.

Omics: Deep quantitative proteome analysis.

Omics: DNA methylation analysis.

Omics: Protein expression by reverse-phase protein arrays.

Omics: SNP array analysis.

Omics: Transcriptome analysis by microarray.

Omics: Transcriptome analysis by RNAseq.

Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.

PubMed=4005855

Kyoizumi S., Akiyama M., Kouno N., Kobuke K., Hakoda M., Jones S.L., Yamakido M.

Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.

Cancer Res. 45:3274-3281(1985)

 

PubMed=3518877; DOI=10.3109/07357908609038260

Fogh J.

Human tumor lines for cancer research.

Cancer Invest. 4:157-184(1986)

 

PubMed=3335022

Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R.

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Cancer Res. 48:589-601(1988)

 

PubMed=8385084; DOI=10.1111/j.1349-7006.1993.tb02851.x; PMCID=PMC5919128

Suzuki S., Takahashi T., Nakamura S., Koike K., Ariyoshi Y., Takahashi T., Ueda R.

Alterations of integrin expression in human lung cancer.

Jpn. J. Cancer Res. 84:168-174(1993)

 

PubMed=7736387; DOI=10.1002/1097-0142(19950515)75:10<2442::AID-CNCR2820751009>3.0.CO;2-Q

Campling B.G., Sarda I.R., Baer K.A., Pang S.C., Baker H.M., Lofters W.S., Flynn T.G.

Secretion of atrial natriuretic peptide and vasopressin by small cell lung cancer.

Cancer 75:2442-2451(1995)

 

PubMed=11583962; DOI=10.1016/S0002-9440(10)62521-7; PMCID=PMC1850523

Haruki N., Harano T., Masuda A., Kiyono T., Takahashi T., Tatematsu Y., Shimizu S., Mitsudomi T., Konishi H., Osada H., Fujii Y., Takahashi T.

Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation.

Am. J. Pathol. 159:1345-1352(2001)

 

PubMed=12794755; DOI=10.1002/ijc.11184

Endoh H., Yatabe Y., Shimizu S., Tajima K., Kuwano H., Takahashi T., Mitsudomi T.

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

Int. J. Cancer 106:45-51(2003)

 

PubMed=14581340

Yokoi S., Yasui K., Iizasa T., Imoto I., Fujisawa T., Inazawa J.

TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.

Clin. Cancer Res. 9:4705-4713(2003)

 

PubMed=15746151; DOI=10.1093/hmg/ddi092

Izumi H., Inoue J., Yokoi S., Hosoda H., Shibata T., Sunamori M., Hirohashi S., Inazawa J., Imoto I.

Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers.

Hum. Mol. Genet. 14:997-1007(2005)

 

PubMed=16187286; DOI=10.1002/ijc.21491

Garnis C., Lockwood W.W., Vucic E., Ge Y., Girard L., Minna J.D., Gazdar A.F., Lam S., MacAulay C., Lam W.L.

High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH.

Int. J. Cancer 118:1556-1564(2006)

 

PubMed=18083107; DOI=10.1016/j.cell.2007.11.025

Rikova K., Guo A.-L., Zeng Q.-F., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y.-R., Tan Z.-P., Stokes M.P., Sullivan L., Mitchell J., Wetzel R., MacNeill J., Ren J.-M., Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D.-Q., Zhou X.-M., Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

Cell 131:1190-1203(2007)